nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—P-Glycoprotein Inhibitors—Vemurafenib—melanoma	0.821	1	CiPCiCtD
Ranolazine—CYP3A4—Temozolomide—melanoma	0.0358	0.385	CbGbCtD
Ranolazine—CYP2D6—Vemurafenib—melanoma	0.0308	0.332	CbGbCtD
Ranolazine—CYP3A4—Vemurafenib—melanoma	0.0196	0.211	CbGbCtD
Ranolazine—CYP3A4—Docetaxel—melanoma	0.00672	0.0724	CbGbCtD
Ranolazine—Electrocardiogram QT prolonged—Vemurafenib—melanoma	0.00143	0.0251	CcSEcCtD
Ranolazine—Pulmonary fibrosis—Bleomycin—melanoma	0.00127	0.0222	CcSEcCtD
Ranolazine—Pulmonary fibrosis—Carmustine—melanoma	0.00111	0.0194	CcSEcCtD
Ranolazine—Pulmonary fibrosis—Temozolomide—melanoma	0.00107	0.0187	CcSEcCtD
Ranolazine—Altered state of consciousness—Temozolomide—melanoma	0.00102	0.0179	CcSEcCtD
Ranolazine—Nephropathy toxic—Bleomycin—melanoma	0.00097	0.017	CcSEcCtD
Ranolazine—Nephropathy toxic—Carmustine—melanoma	0.000846	0.0149	CcSEcCtD
Ranolazine—Levobupivacaine—SCN10A—melanoma	0.000761	0.263	CrCbGaD
Ranolazine—Parosmia—Temozolomide—melanoma	0.000724	0.0127	CcSEcCtD
Ranolazine—Pulmonary fibrosis—Docetaxel—melanoma	0.00071	0.0125	CcSEcCtD
Ranolazine—Pain in extremity—Vemurafenib—melanoma	0.000667	0.0117	CcSEcCtD
Ranolazine—Carvedilol—HIF1A—melanoma	0.00065	0.225	CrCbGaD
Ranolazine—Bupivacaine—SCN10A—melanoma	0.000608	0.211	CrCbGaD
Ranolazine—Eosinophilia—Vemurafenib—melanoma	0.000571	0.01	CcSEcCtD
Ranolazine—Weight decreased—Vemurafenib—melanoma	0.000522	0.00916	CcSEcCtD
Ranolazine—Gait disturbance—Carmustine—melanoma	0.000498	0.00874	CcSEcCtD
Ranolazine—Coordination abnormal—Carmustine—melanoma	0.000495	0.00869	CcSEcCtD
Ranolazine—Hearing impaired—Temozolomide—melanoma	0.000493	0.00866	CcSEcCtD
Ranolazine—Ropivacaine—SCN10A—melanoma	0.00049	0.17	CrCbGaD
Ranolazine—Parosmia—Docetaxel—melanoma	0.000482	0.00845	CcSEcCtD
Ranolazine—Gait disturbance—Temozolomide—melanoma	0.000481	0.00845	CcSEcCtD
Ranolazine—Coordination abnormal—Temozolomide—melanoma	0.000478	0.0084	CcSEcCtD
Ranolazine—Depressed level of consciousness—Carmustine—melanoma	0.000469	0.00824	CcSEcCtD
Ranolazine—Oedema peripheral—Vemurafenib—melanoma	0.000455	0.00798	CcSEcCtD
Ranolazine—Depressed level of consciousness—Temozolomide—melanoma	0.000454	0.00796	CcSEcCtD
Ranolazine—Connective tissue disorder—Vemurafenib—melanoma	0.000454	0.00796	CcSEcCtD
Ranolazine—Disorientation—Bleomycin—melanoma	0.000452	0.00793	CcSEcCtD
Ranolazine—Eye disorder—Vemurafenib—melanoma	0.000431	0.00757	CcSEcCtD
Ranolazine—Cardiac disorder—Vemurafenib—melanoma	0.000428	0.00752	CcSEcCtD
Ranolazine—Dermatitis atopic—Docetaxel—melanoma	0.000422	0.00741	CcSEcCtD
Ranolazine—Angiopathy—Vemurafenib—melanoma	0.000419	0.00735	CcSEcCtD
Ranolazine—Mediastinal disorder—Vemurafenib—melanoma	0.000416	0.0073	CcSEcCtD
Ranolazine—Malnutrition—Vemurafenib—melanoma	0.000402	0.00705	CcSEcCtD
Ranolazine—Lethargy—Dactinomycin—melanoma	0.000385	0.00675	CcSEcCtD
Ranolazine—Amnesia—Carmustine—melanoma	0.000376	0.00659	CcSEcCtD
Ranolazine—Hot flush—Temozolomide—melanoma	0.000364	0.0064	CcSEcCtD
Ranolazine—Amnesia—Temozolomide—melanoma	0.000363	0.00637	CcSEcCtD
Ranolazine—Menopausal symptoms—Temozolomide—melanoma	0.000361	0.00634	CcSEcCtD
Ranolazine—Diplopia—Carmustine—melanoma	0.000353	0.00619	CcSEcCtD
Ranolazine—Cough—Vemurafenib—melanoma	0.000351	0.00615	CcSEcCtD
Ranolazine—Diplopia—Temozolomide—melanoma	0.000341	0.00599	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00034	0.00596	CcSEcCtD
Ranolazine—Pancytopenia—Bleomycin—melanoma	0.000332	0.00582	CcSEcCtD
Ranolazine—Hearing impaired—Docetaxel—melanoma	0.000328	0.00576	CcSEcCtD
Ranolazine—Nervous system disorder—Vemurafenib—melanoma	0.000322	0.00565	CcSEcCtD
Ranolazine—Skin disorder—Vemurafenib—melanoma	0.000318	0.00559	CcSEcCtD
Ranolazine—Dehydration—Temozolomide—melanoma	0.000317	0.00557	CcSEcCtD
Ranolazine—Weight decreased—Bleomycin—melanoma	0.000316	0.00555	CcSEcCtD
Ranolazine—Pancytopenia—Dactinomycin—melanoma	0.000309	0.00543	CcSEcCtD
Ranolazine—Breast disorder—Temozolomide—melanoma	0.000308	0.00541	CcSEcCtD
Ranolazine—Hypotension—Vemurafenib—melanoma	0.000306	0.00538	CcSEcCtD
Ranolazine—Haematuria—Bleomycin—melanoma	0.000297	0.00521	CcSEcCtD
Ranolazine—Pancytopenia—Carmustine—melanoma	0.00029	0.00508	CcSEcCtD
Ranolazine—Decreased appetite—Vemurafenib—melanoma	0.000285	0.005	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Vemurafenib—melanoma	0.000283	0.00497	CcSEcCtD
Ranolazine—Fatigue—Vemurafenib—melanoma	0.000283	0.00496	CcSEcCtD
Ranolazine—Constipation—Vemurafenib—melanoma	0.00028	0.00492	CcSEcCtD
Ranolazine—Pancytopenia—Temozolomide—melanoma	0.00028	0.00491	CcSEcCtD
Ranolazine—Hypoaesthesia—Bleomycin—melanoma	0.000278	0.00488	CcSEcCtD
Ranolazine—Dysuria—Temozolomide—melanoma	0.000276	0.00484	CcSEcCtD
Ranolazine—Erectile dysfunction—Temozolomide—melanoma	0.000271	0.00476	CcSEcCtD
Ranolazine—Renal failure—Carmustine—melanoma	0.000267	0.00469	CcSEcCtD
Ranolazine—Weight decreased—Temozolomide—melanoma	0.000267	0.00468	CcSEcCtD
Ranolazine—Carvedilol—VEGFA—melanoma	0.000262	0.0906	CrCbGaD
Ranolazine—Hallucination—Carmustine—melanoma	0.000243	0.00426	CcSEcCtD
Ranolazine—Hypoaesthesia—Carmustine—melanoma	0.000243	0.00426	CcSEcCtD
Ranolazine—Hot flush—Docetaxel—melanoma	0.000242	0.00426	CcSEcCtD
Ranolazine—Oedema peripheral—Carmustine—melanoma	0.00024	0.00422	CcSEcCtD
Ranolazine—Menopausal symptoms—Docetaxel—melanoma	0.00024	0.00422	CcSEcCtD
Ranolazine—Connective tissue disorder—Carmustine—melanoma	0.00024	0.00421	CcSEcCtD
Ranolazine—Visual disturbance—Docetaxel—melanoma	0.000239	0.0042	CcSEcCtD
Ranolazine—Asthenia—Vemurafenib—melanoma	0.000235	0.00413	CcSEcCtD
Ranolazine—Visual impairment—Carmustine—melanoma	0.000235	0.00413	CcSEcCtD
Ranolazine—Hallucination—Temozolomide—melanoma	0.000235	0.00412	CcSEcCtD
Ranolazine—Hypoaesthesia—Temozolomide—melanoma	0.000235	0.00412	CcSEcCtD
Ranolazine—Urinary tract disorder—Temozolomide—melanoma	0.000233	0.00409	CcSEcCtD
Ranolazine—Oedema peripheral—Temozolomide—melanoma	0.000232	0.00408	CcSEcCtD
Ranolazine—Pruritus—Vemurafenib—melanoma	0.000232	0.00407	CcSEcCtD
Ranolazine—Connective tissue disorder—Temozolomide—melanoma	0.000232	0.00407	CcSEcCtD
Ranolazine—Lethargy—Docetaxel—melanoma	0.000231	0.00406	CcSEcCtD
Ranolazine—Urethral disorder—Temozolomide—melanoma	0.000231	0.00406	CcSEcCtD
Ranolazine—Eye disorder—Carmustine—melanoma	0.000228	0.004	CcSEcCtD
Ranolazine—Visual impairment—Temozolomide—melanoma	0.000227	0.00399	CcSEcCtD
Ranolazine—Pain in extremity—Docetaxel—melanoma	0.000227	0.00398	CcSEcCtD
Ranolazine—Eye disorder—Temozolomide—melanoma	0.00022	0.00387	CcSEcCtD
Ranolazine—Tinnitus—Temozolomide—melanoma	0.00022	0.00386	CcSEcCtD
Ranolazine—Cardiac disorder—Temozolomide—melanoma	0.000219	0.00384	CcSEcCtD
Ranolazine—Arrhythmia—Carmustine—melanoma	0.000218	0.00383	CcSEcCtD
Ranolazine—Leukopenia—Bleomycin—melanoma	0.000218	0.00383	CcSEcCtD
Ranolazine—Dizziness—Vemurafenib—melanoma	0.000217	0.00381	CcSEcCtD
Ranolazine—Angiopathy—Temozolomide—melanoma	0.000214	0.00376	CcSEcCtD
Ranolazine—Mental disorder—Carmustine—melanoma	0.000214	0.00375	CcSEcCtD
Ranolazine—Mediastinal disorder—Temozolomide—melanoma	0.000213	0.00373	CcSEcCtD
Ranolazine—Malnutrition—Carmustine—melanoma	0.000212	0.00373	CcSEcCtD
Ranolazine—Cough—Bleomycin—melanoma	0.000212	0.00373	CcSEcCtD
Ranolazine—Dehydration—Docetaxel—melanoma	0.000211	0.0037	CcSEcCtD
Ranolazine—Vomiting—Vemurafenib—melanoma	0.000208	0.00366	CcSEcCtD
Ranolazine—Orthostatic hypotension—Docetaxel—melanoma	0.000207	0.00364	CcSEcCtD
Ranolazine—Rash—Vemurafenib—melanoma	0.000207	0.00363	CcSEcCtD
Ranolazine—Mental disorder—Temozolomide—melanoma	0.000207	0.00363	CcSEcCtD
Ranolazine—Dermatitis—Vemurafenib—melanoma	0.000207	0.00363	CcSEcCtD
Ranolazine—Headache—Vemurafenib—melanoma	0.000205	0.00361	CcSEcCtD
Ranolazine—Malnutrition—Temozolomide—melanoma	0.000205	0.0036	CcSEcCtD
Ranolazine—Breast disorder—Docetaxel—melanoma	0.000205	0.0036	CcSEcCtD
Ranolazine—Cramp muscle—Docetaxel—melanoma	0.000204	0.00358	CcSEcCtD
Ranolazine—Leukopenia—Dactinomycin—melanoma	0.000203	0.00357	CcSEcCtD
Ranolazine—Confusional state—Bleomycin—melanoma	0.0002	0.00352	CcSEcCtD
Ranolazine—Vision blurred—Carmustine—melanoma	0.0002	0.00352	CcSEcCtD
Ranolazine—Tremor—Carmustine—melanoma	0.000199	0.00349	CcSEcCtD
Ranolazine—Nausea—Vemurafenib—melanoma	0.000195	0.00342	CcSEcCtD
Ranolazine—Thrombocytopenia—Bleomycin—melanoma	0.000195	0.00341	CcSEcCtD
Ranolazine—Vision blurred—Temozolomide—melanoma	0.000194	0.0034	CcSEcCtD
Ranolazine—Tremor—Temozolomide—melanoma	0.000192	0.00338	CcSEcCtD
Ranolazine—Leukopenia—Carmustine—melanoma	0.00019	0.00334	CcSEcCtD
Ranolazine—Anorexia—Bleomycin—melanoma	0.000189	0.00332	CcSEcCtD
Ranolazine—Angioedema—Temozolomide—melanoma	0.000188	0.00329	CcSEcCtD
Ranolazine—Pancytopenia—Docetaxel—melanoma	0.000186	0.00327	CcSEcCtD
Ranolazine—Hypotension—Bleomycin—melanoma	0.000186	0.00326	CcSEcCtD
Ranolazine—Vertigo—Temozolomide—melanoma	0.000184	0.00324	CcSEcCtD
Ranolazine—Leukopenia—Temozolomide—melanoma	0.000184	0.00323	CcSEcCtD
Ranolazine—Palpitations—Temozolomide—melanoma	0.000181	0.00319	CcSEcCtD
Ranolazine—Thrombocytopenia—Dactinomycin—melanoma	0.000181	0.00318	CcSEcCtD
Ranolazine—Anxiety—Carmustine—melanoma	0.00018	0.00316	CcSEcCtD
Ranolazine—Cough—Temozolomide—melanoma	0.000179	0.00315	CcSEcCtD
Ranolazine—Paraesthesia—Bleomycin—melanoma	0.000178	0.00313	CcSEcCtD
Ranolazine—Weight decreased—Docetaxel—melanoma	0.000177	0.00311	CcSEcCtD
Ranolazine—Dyspnoea—Bleomycin—melanoma	0.000177	0.00311	CcSEcCtD
Ranolazine—Anorexia—Dactinomycin—melanoma	0.000177	0.0031	CcSEcCtD
Ranolazine—Confusional state—Carmustine—melanoma	0.000175	0.00307	CcSEcCtD
Ranolazine—Anxiety—Temozolomide—melanoma	0.000174	0.00306	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000174	0.00305	CcSEcCtD
Ranolazine—Decreased appetite—Bleomycin—melanoma	0.000173	0.00303	CcSEcCtD
Ranolazine—Renal failure—Docetaxel—melanoma	0.000172	0.00302	CcSEcCtD
Ranolazine—Dry mouth—Temozolomide—melanoma	0.000171	0.003	CcSEcCtD
Ranolazine—Thrombocytopenia—Carmustine—melanoma	0.00017	0.00298	CcSEcCtD
Ranolazine—Confusional state—Temozolomide—melanoma	0.000169	0.00297	CcSEcCtD
Ranolazine—Anorexia—Carmustine—melanoma	0.000165	0.0029	CcSEcCtD
Ranolazine—Epistaxis—Docetaxel—melanoma	0.000165	0.00289	CcSEcCtD
Ranolazine—Nervous system disorder—Temozolomide—melanoma	0.000164	0.00289	CcSEcCtD
Ranolazine—Thrombocytopenia—Temozolomide—melanoma	0.000164	0.00288	CcSEcCtD
Ranolazine—Feeling abnormal—Bleomycin—melanoma	0.000164	0.00287	CcSEcCtD
Ranolazine—Skin disorder—Temozolomide—melanoma	0.000163	0.00286	CcSEcCtD
Ranolazine—Hypotension—Carmustine—melanoma	0.000162	0.00284	CcSEcCtD
Ranolazine—Hyperhidrosis—Temozolomide—melanoma	0.000162	0.00284	CcSEcCtD
Ranolazine—Decreased appetite—Dactinomycin—melanoma	0.000161	0.00283	CcSEcCtD
Ranolazine—Fatigue—Dactinomycin—melanoma	0.00016	0.0028	CcSEcCtD
Ranolazine—Anorexia—Temozolomide—melanoma	0.00016	0.0028	CcSEcCtD
Ranolazine—Urticaria—Bleomycin—melanoma	0.000158	0.00277	CcSEcCtD
Ranolazine—Insomnia—Carmustine—melanoma	0.000157	0.00275	CcSEcCtD
Ranolazine—Hypoaesthesia—Docetaxel—melanoma	0.000156	0.00274	CcSEcCtD
Ranolazine—Paraesthesia—Carmustine—melanoma	0.000156	0.00273	CcSEcCtD
Ranolazine—Urinary tract disorder—Docetaxel—melanoma	0.000155	0.00272	CcSEcCtD
Ranolazine—Dyspnoea—Carmustine—melanoma	0.000155	0.00271	CcSEcCtD
Ranolazine—Oedema peripheral—Docetaxel—melanoma	0.000155	0.00271	CcSEcCtD
Ranolazine—Somnolence—Carmustine—melanoma	0.000154	0.00271	CcSEcCtD
Ranolazine—Connective tissue disorder—Docetaxel—melanoma	0.000154	0.00271	CcSEcCtD
Ranolazine—Urethral disorder—Docetaxel—melanoma	0.000154	0.0027	CcSEcCtD
Ranolazine—Feeling abnormal—Dactinomycin—melanoma	0.000153	0.00268	CcSEcCtD
Ranolazine—Insomnia—Temozolomide—melanoma	0.000152	0.00266	CcSEcCtD
Ranolazine—Gastrointestinal pain—Dactinomycin—melanoma	0.000152	0.00266	CcSEcCtD
Ranolazine—Visual impairment—Docetaxel—melanoma	0.000151	0.00265	CcSEcCtD
Ranolazine—Decreased appetite—Carmustine—melanoma	0.000151	0.00265	CcSEcCtD
Ranolazine—Paraesthesia—Temozolomide—melanoma	0.00015	0.00264	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Carmustine—melanoma	0.00015	0.00263	CcSEcCtD
Ranolazine—Dyspnoea—Temozolomide—melanoma	0.000149	0.00262	CcSEcCtD
Ranolazine—Somnolence—Temozolomide—melanoma	0.000149	0.00262	CcSEcCtD
Ranolazine—Constipation—Carmustine—melanoma	0.000148	0.0026	CcSEcCtD
Ranolazine—Dyspepsia—Temozolomide—melanoma	0.000148	0.00259	CcSEcCtD
Ranolazine—Eye disorder—Docetaxel—melanoma	0.000147	0.00257	CcSEcCtD
Ranolazine—Abdominal pain—Dactinomycin—melanoma	0.000146	0.00257	CcSEcCtD
Ranolazine—Decreased appetite—Temozolomide—melanoma	0.000146	0.00256	CcSEcCtD
Ranolazine—Cardiac disorder—Docetaxel—melanoma	0.000146	0.00256	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Temozolomide—melanoma	0.000145	0.00254	CcSEcCtD
Ranolazine—Fatigue—Temozolomide—melanoma	0.000144	0.00254	CcSEcCtD
Ranolazine—Constipation—Temozolomide—melanoma	0.000143	0.00252	CcSEcCtD
Ranolazine—Feeling abnormal—Carmustine—melanoma	0.000143	0.00251	CcSEcCtD
Ranolazine—Asthenia—Bleomycin—melanoma	0.000143	0.0025	CcSEcCtD
Ranolazine—Angiopathy—Docetaxel—melanoma	0.000142	0.0025	CcSEcCtD
Ranolazine—Gastrointestinal pain—Carmustine—melanoma	0.000142	0.00249	CcSEcCtD
Ranolazine—Mediastinal disorder—Docetaxel—melanoma	0.000141	0.00248	CcSEcCtD
Ranolazine—Pruritus—Bleomycin—melanoma	0.000141	0.00247	CcSEcCtD
Ranolazine—Arrhythmia—Docetaxel—melanoma	0.00014	0.00246	CcSEcCtD
Ranolazine—Feeling abnormal—Temozolomide—melanoma	0.000138	0.00242	CcSEcCtD
Ranolazine—Mental disorder—Docetaxel—melanoma	0.000137	0.00241	CcSEcCtD
Ranolazine—Abdominal pain—Carmustine—melanoma	0.000137	0.00241	CcSEcCtD
Ranolazine—Gastrointestinal pain—Temozolomide—melanoma	0.000137	0.00241	CcSEcCtD
Ranolazine—Malnutrition—Docetaxel—melanoma	0.000137	0.0024	CcSEcCtD
Ranolazine—Urticaria—Temozolomide—melanoma	0.000133	0.00234	CcSEcCtD
Ranolazine—Asthenia—Dactinomycin—melanoma	0.000133	0.00233	CcSEcCtD
Ranolazine—Abdominal pain—Temozolomide—melanoma	0.000132	0.00233	CcSEcCtD
Ranolazine—Muscle spasms—Docetaxel—melanoma	0.000131	0.0023	CcSEcCtD
Ranolazine—Vomiting—Bleomycin—melanoma	0.000126	0.00222	CcSEcCtD
Ranolazine—Rash—Bleomycin—melanoma	0.000125	0.0022	CcSEcCtD
Ranolazine—Dermatitis—Bleomycin—melanoma	0.000125	0.0022	CcSEcCtD
Ranolazine—Asthenia—Carmustine—melanoma	0.000124	0.00218	CcSEcCtD
Ranolazine—SCN5A—L1CAM interactions—ITGB1—melanoma	0.000123	0.00465	CbGpPWpGaD
Ranolazine—Syncope—Docetaxel—melanoma	0.000122	0.00215	CcSEcCtD
Ranolazine—Leukopenia—Docetaxel—melanoma	0.000122	0.00215	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—RAC2—melanoma	0.000121	0.00458	CbGpPWpGaD
Ranolazine—Palpitations—Docetaxel—melanoma	0.000121	0.00212	CcSEcCtD
Ranolazine—Asthenia—Temozolomide—melanoma	0.00012	0.00211	CcSEcCtD
Ranolazine—Loss of consciousness—Docetaxel—melanoma	0.00012	0.00211	CcSEcCtD
Ranolazine—Cough—Docetaxel—melanoma	0.000119	0.00209	CcSEcCtD
Ranolazine—SCN5A—Axon guidance—SCN10A—melanoma	0.000119	0.0045	CbGpPWpGaD
Ranolazine—Pruritus—Temozolomide—melanoma	0.000119	0.00208	CcSEcCtD
Ranolazine—SCN9A—L1CAM interactions—MAP2K1—melanoma	0.000119	0.00449	CbGpPWpGaD
Ranolazine—Nausea—Bleomycin—melanoma	0.000118	0.00207	CcSEcCtD
Ranolazine—Vomiting—Dactinomycin—melanoma	0.000118	0.00207	CcSEcCtD
Ranolazine—Rash—Dactinomycin—melanoma	0.000117	0.00205	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—NODAL—melanoma	0.000116	0.00438	CbGpPWpGaD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000115	0.00203	CcSEcCtD
Ranolazine—Dizziness—Carmustine—melanoma	0.000115	0.00201	CcSEcCtD
Ranolazine—CYP2D6—Melatonin metabolism and effects—CYP1B1—melanoma	0.000114	0.00432	CbGpPWpGaD
Ranolazine—Dry mouth—Docetaxel—melanoma	0.000114	0.002	CcSEcCtD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—FGF2—melanoma	0.000113	0.00427	CbGpPWpGaD
Ranolazine—Confusional state—Docetaxel—melanoma	0.000112	0.00197	CcSEcCtD
Ranolazine—Dizziness—Temozolomide—melanoma	0.000111	0.00195	CcSEcCtD
Ranolazine—Vomiting—Carmustine—melanoma	0.00011	0.00194	CcSEcCtD
Ranolazine—Nausea—Dactinomycin—melanoma	0.00011	0.00193	CcSEcCtD
Ranolazine—Shock—Docetaxel—melanoma	0.00011	0.00192	CcSEcCtD
Ranolazine—Rash—Carmustine—melanoma	0.000109	0.00192	CcSEcCtD
Ranolazine—Nervous system disorder—Docetaxel—melanoma	0.000109	0.00192	CcSEcCtD
Ranolazine—Dermatitis—Carmustine—melanoma	0.000109	0.00192	CcSEcCtD
Ranolazine—CYP3A4—Estrogen metabolism—CYP1B1—melanoma	0.000109	0.00413	CbGpPWpGaD
Ranolazine—Thrombocytopenia—Docetaxel—melanoma	0.000109	0.00192	CcSEcCtD
Ranolazine—Headache—Carmustine—melanoma	0.000109	0.00191	CcSEcCtD
Ranolazine—Skin disorder—Docetaxel—melanoma	0.000108	0.0019	CcSEcCtD
Ranolazine—Vomiting—Temozolomide—melanoma	0.000107	0.00187	CcSEcCtD
Ranolazine—SCN5A—L1CAM interactions—ITGB3—melanoma	0.000107	0.00403	CbGpPWpGaD
Ranolazine—Anorexia—Docetaxel—melanoma	0.000106	0.00186	CcSEcCtD
Ranolazine—Rash—Temozolomide—melanoma	0.000106	0.00185	CcSEcCtD
Ranolazine—Dermatitis—Temozolomide—melanoma	0.000106	0.00185	CcSEcCtD
Ranolazine—Headache—Temozolomide—melanoma	0.000105	0.00184	CcSEcCtD
Ranolazine—Hypotension—Docetaxel—melanoma	0.000104	0.00183	CcSEcCtD
Ranolazine—SCN5A—L1CAM interactions—MAP2K2—melanoma	0.000104	0.00394	CbGpPWpGaD
Ranolazine—Nausea—Carmustine—melanoma	0.000103	0.00181	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—DCX—melanoma	0.000102	0.00388	CbGpPWpGaD
Ranolazine—Insomnia—Docetaxel—melanoma	0.000101	0.00177	CcSEcCtD
Ranolazine—Paraesthesia—Docetaxel—melanoma	0.0001	0.00176	CcSEcCtD
Ranolazine—Nausea—Temozolomide—melanoma	9.95e-05	0.00175	CcSEcCtD
Ranolazine—Dyspnoea—Docetaxel—melanoma	9.94e-05	0.00174	CcSEcCtD
Ranolazine—Somnolence—Docetaxel—melanoma	9.91e-05	0.00174	CcSEcCtD
Ranolazine—SCN5A—L1CAM interactions—RAC1—melanoma	9.88e-05	0.00374	CbGpPWpGaD
Ranolazine—Dyspepsia—Docetaxel—melanoma	9.81e-05	0.00172	CcSEcCtD
Ranolazine—CYP2D6—Biological oxidations—UGT2B10—melanoma	9.79e-05	0.0037	CbGpPWpGaD
Ranolazine—Decreased appetite—Docetaxel—melanoma	9.69e-05	0.0017	CcSEcCtD
Ranolazine—CYP3A4—Tamoxifen metabolism—CYP1B1—melanoma	9.65e-05	0.00365	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—RHOB—melanoma	9.64e-05	0.00365	CbGpPWpGaD
Ranolazine—Gastrointestinal disorder—Docetaxel—melanoma	9.62e-05	0.00169	CcSEcCtD
Ranolazine—Fatigue—Docetaxel—melanoma	9.61e-05	0.00169	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—DCC—melanoma	9.54e-05	0.00361	CbGpPWpGaD
Ranolazine—Constipation—Docetaxel—melanoma	9.53e-05	0.00167	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—PAX4—melanoma	9.52e-05	0.0036	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—EPHA2—melanoma	9.52e-05	0.0036	CbGpPWpGaD
Ranolazine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—melanoma	9.41e-05	0.00356	CbGpPWpGaD
Ranolazine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—melanoma	9.39e-05	0.00356	CbGpPWpGaD
Ranolazine—CYP2D6—Melatonin metabolism and effects—EDN1—melanoma	9.22e-05	0.00349	CbGpPWpGaD
Ranolazine—Feeling abnormal—Docetaxel—melanoma	9.18e-05	0.00161	CcSEcCtD
Ranolazine—Gastrointestinal pain—Docetaxel—melanoma	9.11e-05	0.0016	CcSEcCtD
Ranolazine—Abdominal pain—Docetaxel—melanoma	8.81e-05	0.00155	CcSEcCtD
Ranolazine—CYP2D6—Melatonin metabolism and effects—PRKCA—melanoma	8.64e-05	0.00327	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—RAC2—melanoma	8.64e-05	0.00327	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—SCN10A—melanoma	8.49e-05	0.00321	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—RHOB—melanoma	8.41e-05	0.00318	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—DCC—melanoma	8.33e-05	0.00315	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—CDH2—melanoma	8.25e-05	0.00312	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—ITGAV—melanoma	8.21e-05	0.00311	CbGpPWpGaD
Ranolazine—Asthenia—Docetaxel—melanoma	8e-05	0.0014	CcSEcCtD
Ranolazine—CYP3A4—Irinotecan Pathway—APC—melanoma	7.93e-05	0.003	CbGpPWpGaD
Ranolazine—Pruritus—Docetaxel—melanoma	7.88e-05	0.00138	CcSEcCtD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—IL10—melanoma	7.62e-05	0.00288	CbGpPWpGaD
Ranolazine—SCN9A—L1CAM interactions—MAPK3—melanoma	7.58e-05	0.00287	CbGpPWpGaD
Ranolazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	7.57e-05	0.00287	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—RAC2—melanoma	7.54e-05	0.00285	CbGpPWpGaD
Ranolazine—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—melanoma	7.47e-05	0.00283	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—ITGB1—melanoma	7.45e-05	0.00282	CbGpPWpGaD
Ranolazine—SCN5A—L1CAM interactions—MAP2K1—melanoma	7.38e-05	0.00279	CbGpPWpGaD
Ranolazine—Dizziness—Docetaxel—melanoma	7.37e-05	0.00129	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—PAX6—melanoma	7.27e-05	0.00275	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—NODAL—melanoma	7.22e-05	0.00273	CbGpPWpGaD
Ranolazine—SCN9A—L1CAM interactions—MAPK1—melanoma	7.21e-05	0.00273	CbGpPWpGaD
Ranolazine—SCN9A—L1CAM interactions—EGFR—melanoma	7.21e-05	0.00273	CbGpPWpGaD
Ranolazine—Vomiting—Docetaxel—melanoma	7.09e-05	0.00124	CcSEcCtD
Ranolazine—Rash—Docetaxel—melanoma	7.03e-05	0.00123	CcSEcCtD
Ranolazine—Dermatitis—Docetaxel—melanoma	7.02e-05	0.00123	CcSEcCtD
Ranolazine—Headache—Docetaxel—melanoma	6.98e-05	0.00123	CcSEcCtD
Ranolazine—Carvedilol—ABCB1—melanoma	6.71e-05	0.0232	CrCbGaD
Ranolazine—Nausea—Docetaxel—melanoma	6.62e-05	0.00116	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—ITGB3—melanoma	6.46e-05	0.00245	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—HIF1A—melanoma	6.42e-05	0.00243	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—UGT2B10—melanoma	6.4e-05	0.00242	CbGpPWpGaD
Ranolazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	6.38e-05	0.00241	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—MAP2K2—melanoma	6.32e-05	0.00239	CbGpPWpGaD
Ranolazine—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—melanoma	6.29e-05	0.00238	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—AKR1B10—melanoma	6.22e-05	0.00235	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	6.14e-05	0.00232	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—RHOB—melanoma	6e-05	0.00227	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—RAC1—melanoma	5.99e-05	0.00227	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—DCC—melanoma	5.94e-05	0.00225	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—AKT3—melanoma	5.86e-05	0.00222	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—ITGAV—melanoma	5.86e-05	0.00222	CbGpPWpGaD
Ranolazine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	5.68e-05	0.00215	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—KDR—melanoma	5.49e-05	0.00208	CbGpPWpGaD
Ranolazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	5.41e-05	0.00205	CbGpPWpGaD
Ranolazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	5.4e-05	0.00204	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—RAC2—melanoma	5.38e-05	0.00204	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—MET—melanoma	5.38e-05	0.00203	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—ITGB1—melanoma	5.32e-05	0.00201	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	5.17e-05	0.00196	CbGpPWpGaD
Ranolazine—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	5.16e-05	0.00195	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—CDH2—melanoma	5.14e-05	0.00195	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—ITGAV—melanoma	5.11e-05	0.00193	CbGpPWpGaD
Ranolazine—Propranolol—ABCB1—melanoma	5.11e-05	0.0177	CrCbGaD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	4.95e-05	0.00187	CbGpPWpGaD
Ranolazine—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	4.89e-05	0.00185	CbGpPWpGaD
Ranolazine—SCN5A—L1CAM interactions—MAPK3—melanoma	4.72e-05	0.00179	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—ITGB1—melanoma	4.64e-05	0.00176	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—ITGB3—melanoma	4.61e-05	0.00174	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—PAX6—melanoma	4.53e-05	0.00171	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MAP2K2—melanoma	4.51e-05	0.00171	CbGpPWpGaD
Ranolazine—SCN5A—L1CAM interactions—MAPK1—melanoma	4.49e-05	0.0017	CbGpPWpGaD
Ranolazine—SCN5A—L1CAM interactions—EGFR—melanoma	4.49e-05	0.0017	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—MMP2—melanoma	4.48e-05	0.0017	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—MAP2K1—melanoma	4.48e-05	0.00169	CbGpPWpGaD
Ranolazine—CYP2D6—Melatonin metabolism and effects—NFKB1—melanoma	4.46e-05	0.00169	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—RAC1—melanoma	4.27e-05	0.00162	CbGpPWpGaD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	4.17e-05	0.00158	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—CXCL8—melanoma	4.17e-05	0.00158	CbGpPWpGaD
Ranolazine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	4.11e-05	0.00156	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	4.07e-05	0.00154	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—ITGB3—melanoma	4.03e-05	0.00152	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	4.01e-05	0.00152	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—CASP3—melanoma	3.99e-05	0.00151	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MAP2K2—melanoma	3.94e-05	0.00149	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—ERBB2—melanoma	3.93e-05	0.00149	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—KDR—melanoma	3.92e-05	0.00148	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—melanoma	3.84e-05	0.00145	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MET—melanoma	3.84e-05	0.00145	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—CDK4—melanoma	3.84e-05	0.00145	CbGpPWpGaD
Ranolazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	3.76e-05	0.00142	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—RAC1—melanoma	3.73e-05	0.00141	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—NFKB1—melanoma	3.73e-05	0.00141	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—NOTCH1—melanoma	3.69e-05	0.0014	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—ITGAV—melanoma	3.65e-05	0.00138	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—AKT3—melanoma	3.65e-05	0.00138	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—PPARG—melanoma	3.49e-05	0.00132	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—KDR—melanoma	3.42e-05	0.0013	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—VEGFA—melanoma	3.38e-05	0.00128	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	3.38e-05	0.00128	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—MMP9—melanoma	3.37e-05	0.00128	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MET—melanoma	3.35e-05	0.00127	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—ITGB1—melanoma	3.31e-05	0.00125	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—CYP17A1—melanoma	3.26e-05	0.00123	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—CYP17A1—melanoma	3.22e-05	0.00122	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MMP2—melanoma	3.2e-05	0.00121	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MAP2K1—melanoma	3.2e-05	0.00121	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—FGF2—melanoma	3.04e-05	0.00115	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—VEGFA—melanoma	3.03e-05	0.00115	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—NRAS—melanoma	2.99e-05	0.00113	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—TNF—melanoma	2.9e-05	0.0011	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—ITGB3—melanoma	2.87e-05	0.00109	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—MAPK3—melanoma	2.86e-05	0.00108	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MAP2K2—melanoma	2.81e-05	0.00106	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—ERBB2—melanoma	2.8e-05	0.00106	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MMP2—melanoma	2.79e-05	0.00106	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MAP2K1—melanoma	2.79e-05	0.00106	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—CYP1B1—melanoma	2.75e-05	0.00104	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—MAPK1—melanoma	2.72e-05	0.00103	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—EGFR—melanoma	2.72e-05	0.00103	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—CYP1B1—melanoma	2.71e-05	0.00102	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—RAC1—melanoma	2.66e-05	0.00101	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—KRAS—melanoma	2.57e-05	0.000974	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—CTNNB1—melanoma	2.45e-05	0.000929	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—ERBB2—melanoma	2.45e-05	0.000926	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—KDR—melanoma	2.44e-05	0.000924	CbGpPWpGaD
Ranolazine—CYP3A4—Tryptophan metabolism—MDM2—melanoma	2.41e-05	0.000912	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MMP9—melanoma	2.41e-05	0.00091	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MET—melanoma	2.39e-05	0.000905	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—CDK4—melanoma	2.39e-05	0.000905	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—NFKB1—melanoma	2.38e-05	0.000901	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—IL6—melanoma	2.34e-05	0.000886	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—NOTCH1—melanoma	2.3e-05	0.000871	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—HRAS—melanoma	2.19e-05	0.000828	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—PPARG—melanoma	2.17e-05	0.000822	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—VEGFA—melanoma	2.16e-05	0.000817	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—STAT3—melanoma	2.14e-05	0.000809	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—NRAS—melanoma	2.13e-05	0.000807	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP17A1—melanoma	2.13e-05	0.000807	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	2.1e-05	0.000796	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MMP9—melanoma	2.1e-05	0.000795	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—IL6—melanoma	2.09e-05	0.000792	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MAPK3—melanoma	2.04e-05	0.000773	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MMP2—melanoma	1.99e-05	0.000755	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MAP2K1—melanoma	1.99e-05	0.000753	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MAPK1—melanoma	1.94e-05	0.000736	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—EGFR—melanoma	1.94e-05	0.000736	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—FGF2—melanoma	1.89e-05	0.000717	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—VEGFA—melanoma	1.89e-05	0.000714	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—NRAS—melanoma	1.86e-05	0.000705	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—TNF—melanoma	1.85e-05	0.000701	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—KRAS—melanoma	1.84e-05	0.000695	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ACER3—melanoma	1.83e-05	0.000693	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP1B1—melanoma	1.79e-05	0.000679	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MAPK3—melanoma	1.78e-05	0.000675	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	1.77e-05	0.00067	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—ERBB2—melanoma	1.75e-05	0.000661	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MAPK1—melanoma	1.7e-05	0.000642	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—EGFR—melanoma	1.7e-05	0.000642	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—UGT2B10—melanoma	1.67e-05	0.000633	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—KRAS—melanoma	1.6e-05	0.000607	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—HRAS—melanoma	1.56e-05	0.000591	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HS3ST5—melanoma	1.56e-05	0.000589	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—CTNNB1—melanoma	1.53e-05	0.000578	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MMP9—melanoma	1.5e-05	0.000567	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—IL6—melanoma	1.49e-05	0.000565	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—NFKB1—melanoma	1.48e-05	0.000561	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—AKT1—melanoma	1.38e-05	0.000522	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—HRAS—melanoma	1.36e-05	0.000516	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—VEGFA—melanoma	1.35e-05	0.000509	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—STAT3—melanoma	1.33e-05	0.000504	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—NRAS—melanoma	1.33e-05	0.000503	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—IL6—melanoma	1.3e-05	0.000494	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MAPK3—melanoma	1.27e-05	0.000482	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MAPK1—melanoma	1.21e-05	0.000458	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—EGFR—melanoma	1.21e-05	0.000458	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ACER3—melanoma	1.2e-05	0.000453	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PLCB4—melanoma	1.18e-05	0.000446	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—TNF—melanoma	1.15e-05	0.000436	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—KRAS—melanoma	1.14e-05	0.000433	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SLC6A11—melanoma	1.11e-05	0.00042	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIP4K2A—melanoma	1.11e-05	0.00042	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—UGT2B10—melanoma	1.09e-05	0.000414	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—MTAP—melanoma	1.08e-05	0.000408	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HS3ST5—melanoma	1.02e-05	0.000385	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—HRAS—melanoma	9.72e-06	0.000368	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PHGDH—melanoma	9.61e-06	0.000364	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—LUM—melanoma	9.61e-06	0.000364	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HPSE—melanoma	9.43e-06	0.000357	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—IL6—melanoma	9.31e-06	0.000352	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CUBN—melanoma	9.25e-06	0.00035	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SDHD—melanoma	8.94e-06	0.000338	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—BSG—melanoma	8.94e-06	0.000338	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CSPG4—melanoma	8.94e-06	0.000338	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GPAM—melanoma	8.66e-06	0.000328	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—AKT1—melanoma	8.59e-06	0.000325	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PLCB4—melanoma	7.71e-06	0.000292	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PLA2G6—melanoma	7.36e-06	0.000279	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIP4K2A—melanoma	7.25e-06	0.000274	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SLC6A11—melanoma	7.25e-06	0.000274	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—MTAP—melanoma	7.05e-06	0.000267	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—VCAN—melanoma	6.61e-06	0.00025	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PHGDH—melanoma	6.29e-06	0.000238	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—LUM—melanoma	6.29e-06	0.000238	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HPSE—melanoma	6.16e-06	0.000233	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CUBN—melanoma	6.05e-06	0.000229	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SDHD—melanoma	5.84e-06	0.000221	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CSPG4—melanoma	5.84e-06	0.000221	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—BSG—melanoma	5.84e-06	0.000221	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GPAM—melanoma	5.66e-06	0.000214	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP17A1—melanoma	5.58e-06	0.000211	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GNA11—melanoma	5.27e-06	0.000199	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—FASN—melanoma	5.15e-06	0.000195	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SLC5A5—melanoma	5.07e-06	0.000192	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GNAQ—melanoma	4.9e-06	0.000185	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CD44—melanoma	4.9e-06	0.000185	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PLA2G6—melanoma	4.81e-06	0.000182	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP1B1—melanoma	4.69e-06	0.000178	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—VCAN—melanoma	4.32e-06	0.000164	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ABCB1—melanoma	3.87e-06	0.000146	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP17A1—melanoma	3.65e-06	0.000138	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PRKCA—melanoma	3.56e-06	0.000135	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ERCC2—melanoma	3.53e-06	0.000134	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GNA11—melanoma	3.44e-06	0.00013	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—FASN—melanoma	3.37e-06	0.000128	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SLC5A5—melanoma	3.31e-06	0.000125	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GNAQ—melanoma	3.2e-06	0.000121	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CD44—melanoma	3.2e-06	0.000121	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP1B1—melanoma	3.07e-06	0.000116	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CG—melanoma	2.79e-06	0.000105	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PPARG—melanoma	2.69e-06	0.000102	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ABCB1—melanoma	2.53e-06	9.57e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CD—melanoma	2.45e-06	9.27e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ALB—melanoma	2.42e-06	9.15e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PRKCA—melanoma	2.33e-06	8.8e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ERCC2—melanoma	2.31e-06	8.73e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CB—melanoma	2.14e-06	8.08e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PTGS2—melanoma	2.12e-06	8.01e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PTEN—melanoma	1.85e-06	6.98e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CG—melanoma	1.82e-06	6.9e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PPARG—melanoma	1.76e-06	6.65e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CD—melanoma	1.6e-06	6.06e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ALB—melanoma	1.58e-06	5.98e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CB—melanoma	1.4e-06	5.28e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PTGS2—melanoma	1.38e-06	5.24e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CA—melanoma	1.3e-06	4.93e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PTEN—melanoma	1.21e-06	4.57e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AKT1—melanoma	1.06e-06	4.02e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CA—melanoma	8.51e-07	3.22e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AKT1—melanoma	6.95e-07	2.63e-05	CbGpPWpGaD
